BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:YN001 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of YN001\, from ClinicalTrials.gov estimates
 .
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07521007-1257@assetmemo.bio
DTSTAMP:20261121T004546Z
DTSTART;VALUE=DATE:20270731
DTEND;VALUE=DATE:20270801
SUMMARY:YN001: Phase 2 readout est. (NCT07521007)
DESCRIPTION:YN001\, phase 2\, Atherosclerotic Cardiovascular Disease.\nStud
 y: A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclero
 sis\nEstimated primary completion: 31 July 2027. This is a ClinicalTrials.
 gov estimate\, not a confirmed readout date\, and it can move.\nDrug page:
  https://assetmemo.bio/drug/yn001#upcoming-events\nRegistry record: https:
 //clinicaltrials.gov/study/NCT07521007
URL:https://assetmemo.bio/drug/yn001#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
